Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Genetics Laboratory, |
RCV001173650 | SCV001336752 | uncertain significance | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Invitae | RCV002559665 | SCV003244557 | uncertain significance | Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency; Charcot-Marie-Tooth disease axonal type 2U | 2023-12-08 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 625 of the MARS protein (p.Arg625Trp). This variant is present in population databases (rs754546247, gnomAD 0.009%). This missense change has been observed in individual(s) with aminoacyl‚ÄëtRNA synthetase abnormalities (PMID: 34585293). ClinVar contains an entry for this variant (Variation ID: 917127). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Diagnostic Laboratory, |
RCV001726443 | SCV001962845 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001726443 | SCV001973830 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
OMIM | RCV003224883 | SCV003918830 | pathogenic | Spastic paraplegia 70, autosomal recessive | 2023-04-19 | no assertion criteria provided | literature only |